Peter Lee has spent a lot of time recently with GPT-4, the AI-powered tool that simulates human conversation, built by OpenAI with contributions from its partner Microsoft.
“I lost a couple weeks of sleep,” said Lee at a lecture Monday at the University of Washington. “It was very intense.”
Lee, head of Microsoft Research, is tasked with assessing the implications of the tool for medicine. And he thinks it could increase efficiency and even empathy in the healthcare system, as well as boost biomedical research.
